Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis

被引:47
|
作者
Woodcock, Ashley [1 ]
Janson, Christer [2 ]
Rees, Jamie [3 ]
Frith, Lucy [3 ]
Lofdahl, Magnus [4 ]
Moore, Alison [5 ]
Hedberg, Martin [6 ]
Leather, David [5 ]
机构
[1] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
[2] Uppsala Univ, Dept Med Sci Resp, Uppsala, Sweden
[3] GlaxoSmithKline R&D, Biostat, Brentford, England
[4] GlaxoSmithKline, Solna, Sweden
[5] GlaxoSmithKline R&D, Resp Therapy Area, Brentford, England
[6] Polyfuture Inst SWC AB, Nacka, Sweden
关键词
asthma; inhaler devices; OBSTRUCTIVE PULMONARY-DISEASE; OPEN-LABEL;
D O I
10.1136/thoraxjnl-2021-218088
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Objective To compare the effects of switching from a pressurised metered dose inhaler (pMDI)-based to a dry powder inhaler (DPI)-based maintenance therapy versus continued usual care on greenhouse gas emissions (carbon dioxide equivalents, CO(2)e) and asthma control. ethods This post-hoc analysis was based on a subset of 2236 (53%) patients from the Salford Lung Study in Asthma who at baseline were using a pMDI-based controller therapy. During the study patients were randomised to fluticasone furoate/vilanterol (FF/VI) via the ELLIPTA DPI (switched from pMDI to DPI) (n=1081) or continued their usual care treatment (n=1155), and were managed in conditions close to everyday clinical practice. Annual CO(2)e (kg) was calculated for the total number of maintenance and rescue inhalers prescribed. Asthma control was assessed by the proportion of ACT responders (composite of ACT total score >= 20 and/or increase from baseline >= 3). Results The groups were well matched for demographic characteristics and baseline Asthma Control Test (ACT) total score (mean age: 49 years; mean ACT score: usual care, 16.6; FF/VI, 16.5). Annual CO(2)e kg per patient (maintenance plus rescue therapy) was significantly lower with FF/VI DPI treatment ('switch' group) than usual care (least squares geometric mean 108 kg (95% CI 102 to 114) vs 240 kg (95% CI 229 to 252), p<0.001). Asthma control was consistently superior over the 12 months in the FF/VI DPI group compared with usual care. Conclusions Patients switching from a pMDI-based to a DPI-based maintenance therapy more than halved their inhaler carbon footprint without loss of asthma control. The remaining inhaler carbon footprint could be reduced through switches from pMDI to DPI rescue medications or alternative lower-carbon footprint rescue inhalers if available. Asthma control improved in both groups, with greater control demonstrated in those initiated on FF/VI DPI.
引用
收藏
页码:1187 / 1192
页数:6
相关论文
共 50 条
  • [31] Efficacy, safety, and acceptance of beclomethasone dipropionate administered via a new dry powder inhaler or a standard CFC metered-dose inhaler in asthma patients
    Kunkel, G
    Schäper, C
    Noga, O
    Schläfke, S
    Lemmnitz, G
    Köhler, S
    RESPIRATION, 2003, 70 (04) : 399 - 406
  • [32] Comparison of extrafine beclomethasone dipropionate/formoterol fumarate dry powder inhaler and pressurized metered-dose inhaler in Chinese patients with asthma: the FORTUNE study
    Zheng, Jinping
    Zhang, Jianyong
    Fu, Xiuhua
    Lin, Changqing
    Zhang, Xinri
    Mei, Xiaodong
    Corradi, Massimo
    Cappellini, Glauco
    Calabro, Emanuele
    Zhu, Cissy
    Topole, Eva
    JOURNAL OF ASTHMA, 2024, 61 (04) : 360 - 367
  • [33] Effect of inhalation flow rate on the dosing characteristics of dry powder inhaler (DPI) and metered dose inhaler (MDI) products
    Ross, DL
    Schultz, RK
    JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 1996, 9 (02): : 215 - 226
  • [34] Comparison of the lung absorption of FK224 inhaled from a pressurized metered dose inhaler and a dry powder inhaler by healthy volunteers
    Nakate, T
    Yoshida, H
    Ohike, A
    Tokunaga, Y
    Ibuki, R
    Kawashima, Y
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2003, 56 (03) : 319 - 325
  • [35] A DOUBLE-BLIND COMPARISON BETWEEN A NEW MULTIDOSE POWDER INHALER (TURBUHALER) AND METERED DOSE INHALER IN CHILDREN WITH ASTHMA
    HULTQUIST, C
    AHLSTROM, H
    KJELLMAN, NIM
    MALMQVIST, LA
    SVENONIUS, E
    MELIN, S
    ALLERGY, 1989, 44 (07) : 467 - 470
  • [36] Comparison of the clinical effects of combined salmeterol/fluticasone delivered by dry powder or pressurized metered dose inhaler
    Hojo, Masayuki
    Shirai, Toshihiro
    Hirashima, Junko
    Iikura, Motoyasu
    Sugiyama, Haruhito
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2016, 37 : 43 - 48
  • [37] Evaluation of inhaler technique, adherence to therapy and their effect on disease control among children with asthma using metered dose or dry powder inhalers
    Capanoglu, Murat
    Misirlioglu, Emine Dibek
    Toyran, Muge
    Civelek, Ersoy
    Kocabas, Can Naci
    JOURNAL OF ASTHMA, 2015, 52 (08) : 838 - 845
  • [38] Comparative bronchodilatory effects of formoterol dry powder inhaler (DPI) versus the combination of formoterol and budesonide pressurized metered-dose inhaler (pMDI)
    Mezzanotte, W. S.
    Miller, C. J.
    Senn, S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S248 - S248
  • [39] Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate
    Wardlaw, A
    Larivee, P
    Eller, J
    Cockcroft, DW
    Ghaly, L
    Harris, AG
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2004, 93 (01) : 49 - 55
  • [40] Comparative efficacy of salbutamol via metered dose inhaler with spacer and dry powder inhaler, easyhaler, in the treatment of methacholine induced bronchoconstriction
    Direkwattanachai, C
    Tarvornpanich, N
    Benjaponpitak, S
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S233 - S233